A 1HMRS study of the anterior cingulate gyrus in euthymic bipolar patients

Human Psychopharmacology

Volumn 21, Issue 4, 2006, Pages 215-220

  Amaral, Jose Antonio de M S ^a,b   Tamada, Renata S ^a   Issler, Cilly K ^a   Caetano, Sheila C ^a   Cerri, Giovanni G ^a   de Castro, Claudio C ^a   Lafer, Beny ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Bipolar disorder; Cingulate gyrus; Mood disorders; NAA; Neuroimaging; Proton magnetic resonance spectroscopy

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHOLINE; CREATINE; LITHIUM; N ACETYLASPARTIC ACID; NEUROLEPTIC AGENT; PROTON; VALPROIC ACID; ASPARTIC ACID; DRUG DERIVATIVE; N-ACETYLASPARTATE;

ADULT; ARTICLE; AUTOMATION; BIPOLAR DISORDER; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DOSE REGIMEN; FEMALE; HAMILTON SCALE; HUMAN; LONG TERM CARE; MALE; NEUROIMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; SIGNAL DETECTION; TREATMENT DURATION; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ADULT; ASPARTIC ACID; BIPOLAR DISORDER; CHOLINE; CREATINE; FEMALE; GYRUS CINGULI; HUMANS; LITHIUM; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED;

EID: 33745912488     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.761     Document Type: Article

References (41)

1. Aydemir O, Deveci A, Taneli F. 2005. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 29: 261-265.
2. Benes FM, Vincent SL, odtenkopf M. 2001, The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol Psychiatry 50: 395-406.
3. Bertolino A, Frye M, Callicott JH, et al. 2003. Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol Psychiatry 53: 906-913.
4. 1H magnetic resonance spectroscopy in brain diseases. Brain Res Brain Res Rev 33: 380-389.
5. Bouras C, Kovari E, Hof PR, Riederer BM, Giannakopoulos P. 2001. Anterior cingulate cortex pathology in schizophrenia and bipolar disorder. Acta Neuropathol (Berl) 102: 373-379.
6. Braus DF, Ende G, Weber-Fahr W, Demirakca T, Henn FA. 2001. Favorable effect on neuronal viability in the anterior cingulate gyrus due to long-term treatment with atypical antipsychotics: an MRSI study. Pharmacopsychiatry 34: 251-253.
7. Brooks JC, Roberts N, Kemp GJ, Gosney MA, Lye M, Whitehouse GH. 2001. A proton magnetic resonance spectroscopy study of age-related changes in frontal lobe metabolite concentrations. Cerebral Cortex 11: 598-605.
8. Brunello N. 2004. Mood stabilizers: protecting the mood...protect-protecting the brain. J Affect Disord 79 (Suppl. 1):S15-S20.
9. Cecil KM, DelBello MP, Morey R, Strakowski SM. 2002. Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. Bipolar Disord 4: 357-365.
10. Chana G, Landau S, Beasley C, Everall IP, Cotter D. 2003. Two-dimensional assessment of cytoarchitecture, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density. Biol Psychiatry 53: 1086-1098.
11. Charles HC, Lazeyras F, Krishnan KR, Boyko OB, Patterson LJ, Doraiswamy PM, McDonald WM. 1994. Proton spectroscopy of human brain: effects of age and sex. Prog Neuropsychopharmacol Biol Psychiatry 18: 995-1004.
12. Cummings JL. 1993. Frontal-subcortical circuits and human behavior. Arch Neurol 50: 873-880.
13. Davanzo P, Thomas MA, Yue K, et al. 2001. Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder. Neuropsychopharmacology 24: 359-369.
14. Devinsky O, Morrell MJ, Vogt BA. 1995. Contributions of anterior cingulate cortex to behaviour. Brain 118: 279-306.
15. Doris A, Belton E, Ebmeier KP, Glabus MP, Marshall I. 2004. Reduction of cingulate gray matter density in poor outcome bipolar illness. Psychiatry Res 130: 153-159.
16. Drevets WC, Price JL, Simpson JR Jr, et al. 1997. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386: 824-827.
17. Duman RS, Heninger GR, Nestler EJ. 1997. A molecular and cellular theory of depression. Arch Gen Psychiatry 54: 597-606.
18. Eastwood SL, Harrison PJ. 2001. Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders: a review and a Western blot study of synaptophysin, GAP-43 and the complexins. Brain Res Bull 55: 569-578.
19. First MB, Spitzer RL, Gibbon M, Williams JB. 1997. Structured Clinical Interview for DSM-IV Axis I Disorders - Clinician Version (SCID-CV). American Psychiatric Press: Washington, DC.
20. Friedman SD, Dager SR, Parow A, et al. 2004. Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder. Biol Psychiatry Biol Psychiatry 56: 340-348.
21. Hamakawa H, Kato T, Shioiri T, Inubusbi T, Kato N. 1999. Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder. Psychol Med 29: 639-644.
22. Hamilton M. 1967. Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology 6: 278-296.
23. Hirayasu Y, Shenton ME, Salisbury DF, et al. 1999. Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry 156: 1091-1093.
24. Lopez-Larson MP, DelBello MP, Zimmerman ME, Schwiers ML, Strakowski SM. 2002. Regional prefrontal gray and white matter abnormalities in bipolar disorder. Biol Psychiatry 52: 93-100.
25. Lyoo IK, Kim MJ, Stoll AL, et al. 2004. Frontal lobe gray matter density decreases in bipolar I disorder. Biol Psychiatry 55: 648-651.
26. Manji HK, Potter WZ, Lenox RH. 1995. Signal transduction pathways: molecular targets for lithium's actions. Arch Gen Psychiatry 52: 531-543.
27. Manji HK, Moore GJ, Chen G. 2000. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. J Clin Psychiatry 61 (Suppl. 9):82-96.
28. 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 4: 47-52.
29. Moore CM, Breeze JL, Gruber SA, et al. 2000a. Choline, myoinositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex. Bipolar Disord 2: 207-216.
30. Moore GJ, Bebchuk JM, Hasanat K, et al. 2000b. Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects? Biol Psychiatry 48: 1-8.
31. Ongur D, Drevets WC, Price JL. 1998. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 95: 13290-13295.
32. Ross B, Michaelis T. 1994. Clinical applications of magnetic resonance spectroscopy. Magn Reson Q 10: 191-247.
33. Sassi RB, Brambilla P, Hatch JP, et al. 2004. Reduced left anterior cingulate volumes in untreated bipolar patients. Biol Psychiatry 56: 467-475.
34. Sharma V, Menon R, Carr TJ, Densmore M, Mazmanian D, Williamson PC, 2003. An MRI study of subgenual prefrontal cortex in patients with familial and non-familial bipolar I disorder. J Affect Disord 77: 167-171.
35. Shimizu E, Hashimoto K, Okamura N, et al. 2003. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54: 70-75.
36. Soares JC, Boada F, Spencer S, et al. 1999. NAA and choline measures in the anterior cingulate of bipolar disorder patients. Biol Psychiatry 45: 119S-119S.
37. Strakowski SM, Delbello MP, Adler CM. 2005. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Mol Psychiatry 10: 105-116.
38. Tsai G, Coyle JT. 1995. N-acetylaspartate in neuropsychiatric disorders. Prog Neurobiol 46: 531-540.
39. Willmore LJ. 2005. Antiepileptic drugs and neuroprotection: current status and future roles. Epilepsy Behav 7 (Suppl. 3):25-28.
40. Winsberg ME, Sachs N, Tate DL, Adalsteinsson E, Spielman D, Ketter TA. 2000. Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biol Psychiatry 47: 475-481.
41. Young RC, Biggs JT, Ziegler VE, Meyer DA. 1978. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133: 429-435.